Research output per year
Research output per year
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
A randomized controlled trial on the efficacy of life review therapy targeting incurably ill cancer patients: do their informal caregivers benefit?
Kleijn, G., Lissenberg-Witte, B. I., Bohlmeijer, E. T., Willemsen, V., Becker-Commissaris, A., Eeltink, C. M., Bruynzeel, A. M. E., van der Vorst, M. J., Cuijpers, P. & Verdonck-de Leeuw, I. M., Mar 2021, In: Supportive Care in Cancer. 29, 3, p. 1257-1264 8 p.Research output: Contribution to journal › Article › Academic › peer-review
Open Access -
Dose accumulation for personalized stereotactic MR-guided adaptive radiation therapy in prostate cancer
Bohoudi, O., Bruynzeel, A. M. E., Tetar, S., Slotman, B. J., Palacios, M. A. & Lagerwaard, F. J., Apr 2021, In: Radiotherapy and Oncology. 157, p. 197-202 6 p.Research output: Contribution to journal › Article › Academic › peer-review
-
ESTRO-ACROP recommendations on the clinical implementation of hybrid MR-linac systems in radiation oncology
Corradini, S., Alongi, F., Andratschke, N., Azria, D., Bohoudi, O., Boldrini, L., Bruynzeel, A., Hörner-Rieber, J., Jürgenliemk-Schulz, I., Lagerwaard, F., McNair, H., Raaymakers, B., Schytte, T., Tree, A., Valentini, V., Wilke, L., Zips, D. & Belka, C., Jun 2021, In: Radiotherapy and Oncology. 159, p. 146-154 9 p.Research output: Contribution to journal › Article › Academic › peer-review
-
Impact of Daily Plan Adaptation on Organ-At-Risk Normal Tissue Complication Probability for Adrenal Lesions undergoing Stereotactic Ablative Radiation Therapy: NTCP advantages of adaptive MR-guided adrenal SABR
Chen, H., Schneiders, F. L., M E Bruynzeel, A., Lagerwaard, F. J., van Sornsen de Koste, J. R., Cobussen, P., Bohoudi, O., Slotman, B. J., Louie, A. V. & Senan, S., Oct 2021, In: Radiotherapy and Oncology. 163, p. 14-20 7 p.Research output: Contribution to journal › Article › Academic › peer-review
-
Magnetic Resonance-guided Stereotactic Radiotherapy for Localized Prostate Cancer: Final Results on Patient-reported Outcomes of a Prospective Phase 2 Study
Tetar, S. U., Bruynzeel, A. M. E., Oei, S. S., Senan, S., Fraikin, T., Slotman, B. J., Moorselaar, R. J. A. V. & Lagerwaard, F. J., 1 Aug 2021, In: European Urology Oncology. 4, 4, p. 628-634 7 p.Research output: Contribution to journal › Article › Academic › peer-review